medroxyprogesterone acetate has been researched along with Adenocarcinoma, Mucinous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, CL; Freedman, RS; Gallager, HS; Jones, LA; Tan, MT | 1 |
| Adachi, S; Imai, S; Ito, K; Kiyozuka, Y; Nakano, S; Noda, T; Tamori, N; Yoshida, M | 1 |
| Hamerlynck, JV; Mangioni, C; Maskens, AP; Rotmensz, N; van der Burg, ME; Vermorken, JB; Wils, JA | 1 |
3 other study(ies) available for medroxyprogesterone acetate and Adenocarcinoma, Mucinous
| Article | Year |
|---|---|
Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
Topics: Adenocarcinoma, Mucinous; Adult; Age Factors; Aged; Epithelium; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Parity; Receptors, Estrogen; Receptors, Progesterone | 1983 |
[Antiproliferative actions of medroxyprogesterone acetate (MPA) to human ovarian cancer cell lines in vitro].
Topics: Adenocarcinoma, Mucinous; Animals; Biomarkers, Tumor; Cell Division; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Tumor Cells, Cultured | 1992 |
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Evaluation; Drug Resistance; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms | 1985 |